Word

ZYGEL

Status

Dead

Status Code

606

Status Date

Monday, September 11, 2023

Serial Number

88291596

Mark Type

3000

Filing Date

Wednesday, February 6, 2019

Published for Opposition

Tuesday, June 16, 2020

Abandoned Date

Monday, September 11, 2023

Trademark Owner History

Zynerba Pharmaceuticals, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders and all of the foregoing solely derived from manufactured synthetic cannabidiol and which do not contain delta-9 tetrahydrocannabinol (THC)

The mark consists of the word "ZYGEL" in purple stylized text to the left of an arrangement of vertical and horizontal, yellow and orange rectangles with rounded ends featuring three purple teardrop shapes and two red teardrop shapes within a grid pattern created by the rectangles.
The color(s) purple, yellow, orange and red is/are claimed as a feature of the mark.

Trademark Events

Sep 11, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Sep 11, 2023

Abandonment - No Use Statement Filed

Feb 23, 2023

Notice Of Approval Of Extension Request E-Mailed

Feb 22, 2023

Sou Extension 5 Granted

Feb 6, 2023

Sou Extension 5 Filed

Feb 22, 2023

Case Assigned To Intent To Use Paralegal

Feb 6, 2023

Sou Teas Extension Received

Jun 28, 2022

Notice Of Approval Of Extension Request E-Mailed

Jun 24, 2022

Sou Extension 4 Granted

Jun 24, 2022

Sou Extension 4 Filed

Jun 24, 2022

Sou Teas Extension Received

Feb 8, 2022

Notice Of Approval Of Extension Request E-Mailed

Feb 4, 2022

Sou Extension 3 Granted

Feb 4, 2022

Sou Extension 3 Filed

Feb 4, 2022

Sou Teas Extension Received

Jul 13, 2021

Notice Of Approval Of Extension Request E-Mailed

Jul 9, 2021

Sou Extension 2 Granted

Jul 9, 2021

Sou Extension 2 Filed

Jul 9, 2021

Sou Teas Extension Received

Jan 28, 2021

Notice Of Approval Of Extension Request E-Mailed

Jan 26, 2021

Sou Extension 1 Granted

Jan 26, 2021

Sou Extension 1 Filed

Jan 26, 2021

Sou Teas Extension Received

Aug 11, 2020

Noa E-Mailed - Sou Required From Applicant

Jun 16, 2020

Official Gazette Publication Confirmation E-Mailed

Jun 16, 2020

Published For Opposition

May 27, 2020

Notification Of Notice Of Publication E-Mailed

May 6, 2020

Approved For Pub - Principal Register

May 6, 2020

Examiner's Amendment Entered

May 6, 2020

Notification Of Examiners Amendment E-Mailed

May 6, 2020

Examiners Amendment E-Mailed

May 6, 2020

Examiners Amendment -Written

Mar 12, 2020

Teas/Email Correspondence Entered

Mar 11, 2020

Correspondence Received In Law Office

Mar 11, 2020

Teas Response To Office Action Received

Sep 17, 2019

Notification Of Non-Final Action E-Mailed

Sep 17, 2019

Non-Final Action E-Mailed

Sep 17, 2019

Non-Final Action Written

Sep 16, 2019

Assigned To Examiner

Apr 18, 2019

Assigned To Examiner

Apr 18, 2019

Assigned To Examiner

Apr 17, 2019

Preliminary/Voluntary Amendment - Entered

Apr 9, 2019

Assigned To Lie

Apr 5, 2019

Teas Voluntary Amendment Received

Mar 21, 2019

Notice Of Design Search Code E-Mailed

Feb 28, 2019

New Application Office Supplied Data Entered

Feb 9, 2019

New Application Entered